Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Christopher J. Forlenza, Jaclyn Rosenzweig, Audrey Mauguen, Ilia Buhtoiarov, Branko Cuglievan, Hema Dave, Rebecca J. Deyell, Jamie E. Flerlage, Anna K. Franklin, Jennifer Krajewski, Kasey J. Leger, Lianna J. Marks, Robin E. Norris, Martha Pacheco, Faye Willen, Adam Paul Yan, Paul D. Harker-Murray, Lisa Giulino-Roth

Blood Adv (2023) 7 (13): 3225–3231.

https://doi.org/10.1182/bloodadvances.2022009323

Published: 2023

Includes: Supplemental data

Journal Articles

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Kavitha Ramaswamy, Peter G. Steinherz, Anurag K. Agrawal, Christopher J. Forlenza, Audrey Mauguen, Mikhail Roshal, Tanya Trippett, Nancy A. Kernan, Maria Luisa Sulis, Neerav Shukla

Blood Adv (2022) 6 (8): 2688–2694.

https://doi.org/10.1182/bloodadvances.2021005753

Published: 2022

Includes: Supplemental data

Journal Articles

Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma

Christopher J. Forlenza, Nitya Gulati, Audrey Mauguen, Michael J. Absalon, Sharon M. Castellino, Anna Franklin, Frank G. Keller, Neerav Shukla

Blood Adv (2021) 5 (24): 5519–5524.

https://doi.org/10.1182/bloodadvances.2021005268

Published: 2021